Bergmann Travis, Sengupta Shantanu, Bhrushundi Milind P, Kulkarni Hemant, Sengupta Partho P, Fergus Icilma
West Virginia University, School of Public Health, Morgantown, West Virginia, United States.
Sengupta Hospital and Research Institute, Nagpur, India.
Indian Heart J. 2018 Sep-Oct;70(5):630-636. doi: 10.1016/j.ihj.2018.06.018. Epub 2018 Jun 20.
This study sought to determine the association between social support and stigma experienced by HIV-positive patients and presence of subclinical cardiovascular disease.
We implemented a cross sectional study in 67 HIV-positive patients and 52 controls from a community health care center in central India. The participants underwent an in-depth survey and a clinical and laboratory assessment of cardiovascular risk. Carotid-intimal thickness (CIMT) was used as a marker of subclinical cardiovascular disease.
On comparing the HIV and age and sex-matched control population, HIV patients had lower body weight (P=<0.001), and lower systolic blood pressures (P=0.002). Despite the lack of higher cardiac risk factor prevalence and lower lipid abnormalities, HIV patients had higher right, left and average CIMT values than controls (P<0.001 for all). HIV patients also showed higher prevalence of abnormal CIMT (≥ 0.9mm) than controls (32% vs. 0%, P<0.001). HIV patients with increased CIMT (n=37) in comparison with those with normal CIMT (n=30) were more frequently males (P=0.023), had higher systolic blood pressures (P=0.002), lower CD4 counts (P=0.033) and experienced higher enacted stigma (P=0.044). On multivariable stepwise logistic regression, systolic blood pressure (odds ratio:1.06, P=0.002) and stigma score > 25 percentile value (odds ratio:3.84, P=0.037) were independent predictors of the abnormal CIMT.
HIV-positive patients from central India have a higher prevalence of abnormal CIMT as a marker of subclinical cardiovascular disease than the general population. This predisposition to increased cardiovascular risk may be related to complex interactions between HIV disease and stigma-related healthcare inequalities.
本研究旨在确定艾滋病毒阳性患者所经历的社会支持与耻辱感和亚临床心血管疾病的存在之间的关联。
我们在印度中部一个社区医疗中心对67名艾滋病毒阳性患者和52名对照者进行了一项横断面研究。参与者接受了深入调查以及心血管风险的临床和实验室评估。颈动脉内膜中层厚度(CIMT)被用作亚临床心血管疾病的标志物。
与年龄和性别匹配的艾滋病毒对照人群相比,艾滋病毒患者体重较低(P<0.001),收缩压较低(P=0.002)。尽管艾滋病毒患者不存在更高的心脏危险因素患病率且脂质异常较低,但他们的右侧、左侧和平均CIMT值均高于对照组(所有P<0.001)。艾滋病毒患者中CIMT异常(≥0.9mm)的患病率也高于对照组(32%对0%,P<0.001)。与CIMT正常的艾滋病毒患者(n=30)相比,CIMT增加的艾滋病毒患者(n=37)男性更为常见(P=0.023),收缩压更高(P=0.002),CD4细胞计数更低(P=0.033),且经历的实际耻辱感更高(P=0.044)。在多变量逐步逻辑回归分析中,收缩压(比值比:1.06,P=0.002)和耻辱感评分>第25百分位数(比值比:3.84,P=0.037)是CIMT异常的独立预测因素。
来自印度中部的艾滋病毒阳性患者作为亚临床心血管疾病标志物的CIMT异常患病率高于一般人群。这种心血管风险增加的易感性可能与艾滋病毒疾病和耻辱感相关的医疗保健不平等之间的复杂相互作用有关。